Daré Bioscience, Inc. (NASDAQ:DARE – Get Rating) – HC Wainwright issued their FY2027 earnings per share estimates for Daré Bioscience in a research note issued on Friday, March 31st. HC Wainwright analyst D. Tsao expects that the biotechnology company will post earnings of $0.80 per share for the year. HC Wainwright currently has a “Buy” […]
Daré Bioscience, Inc. (NASDAQ:DARE – Get Rating) was the target of a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 466,000 shares, a drop of 15.9% from the February 28th total of 554,100 shares. Based on an average daily trading volume, of 320,500 shares, […]
HC Wainwright reissued their buy rating on shares of Daré Bioscience (NASDAQ:DARE – Get Rating) in a report published on Friday morning, Benzinga reports. HC Wainwright currently has a $7.00 price objective on the biotechnology company’s stock. HC Wainwright also issued estimates for Daré Bioscience’s FY2027 earnings at $0.80 EPS. Several other equities research analysts […]
Daré Bioscience, Inc. (NASDAQ:DARE – Get Rating) was the target of a significant drop in short interest in March. As of March 15th, there was short interest totalling 466,000 shares, a drop of 15.9% from the February 28th total of 554,100 shares. Based on an average trading volume of 320,500 shares, the days-to-cover ratio is […]
Daré Bioscience, Inc. (NASDAQ:DARE – Get Rating) was the recipient of a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 466,000 shares, a decline of 15.9% from the February 28th total of 554,100 shares. Based on an average daily volume of 320,500 shares, the […]